LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with ...
Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures “It is critically important to conduct long-term, real-world studies like CORE ...
You’re noticing patterns—in yourself, your teen, or your child—that just won’t shift. And you’re ready to go deeper. Maybe you’ve tried therapy before. Maybe you’ve worked hard to manage the anxiety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback